Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they will host a virtual Key Opinion Leader (KOL) event on ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing targeted therapies for rare and serious inflammatory conditions, today announced that its ...

NEW YORK, June 25, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) and Silo Pharma, Inc. (NASDAQ: SILO) today announced the formation of a strategic joint venture to develop and ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH), a microcap biotech company with a market capitalization of $16.25 million, reported that its investigational drug HT-001 met at least one primary ...

Hoth Therapeutics is actively seeking strategic global partners for co-development and commercialization opportunities, particularly in Asia. These developments indicate the company’s ongoing ...

(PRNewsfoto/Hoth Therapeutics Inc.) Hoth Therapeutics will host a Key Opinion Leader (KOL) event on June 24, 2025, at 3:30PM EST to highlight recent clinical progress with HT-001, a novel topical ...

HOTH is currently trading at $1.25, up $0.03 or 2.45 percent on hte Nasdaq. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those ...

Hoth Therapeutics' HT-001 Achieves 100% Response Rate in at least one endpoint in Phase 2a Trial in PK Patients for EGFR Inhibitor-Related Skin Toxicities. Hoth Therapeutics will host a Key ...

Hoth Therapeutics, Silo Pharma Launch JV To Commercialize VA-Invented Obesity Drug June 25, 2025 — 08:57 am EDT Written by RTTNews.com for RTTNews -> ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH), a microcap biotech company with a market capitalization of $16.25 million, reported that its investigational drug HT-001 met at least one primary ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biotech firm with strong financial health showing more cash than debt on its balance sheet, and Silo Pharma, Inc. (NASDAQ:SILO) announced Wednesday ...

Mariska Hargitay and Peter Hermann on June 9, 2025. Getty. Her mom, actress Jayne Mansfield, died in a car accident when Hargitay was only 3 years old.